ALBEMARLE CORP
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $5.1B | $5.4B | $9.6B | $7.3B | $3.3B |
| Gross profit | $668.7M | $62.5M | $1.2B | $3.1B | $998.0M |
| Operating income | -$367.1M | -$1.8B | $251.9M | $2.5B | $798.4M |
| Cost of revenue | $4.5B | $5.3B | $8.4B | $4.2B | $2.3B |
| Cash from operations | $1.3B | $687.9M | $1.3B | $1.9B | $344.3M |
| Capital expenditure | $589.8M | $1.7B | $2.2B | $1.3B | $953.7M |
| Free cash flow | $692.5M | -$992.7M | -$828.0M | $646.2M | -$609.4M |
| Impairments | $181.1M | $0 | $0 | $0 | $0 |
| Total assets | $16.4B | $16.6B | $18.3B | $15.5B | $11.0B |
Shares outstanding 117.9M · Free float 96.0%
Annual filing data through FY ended December 31, 2025; float as of July 11, 2026.